PATTERNS OF DUVELISIB‐INDUCED LYMPHOCYTOSIS IN PATIENTS WITH R/R CLL OR SLL INCLUDING THOSE WITH HIGH‐RISK FACTORS TREATED IN THE DUO TRIAL. (12th June 2019) - Barrientos, J.; Flinn, I.; Davids, M.S.; Cashen, A.; Chiorazzi, N.; Chen, S.; Hidy, S.; Pachter, J.; Lustgarten, S.; Weaver, D.T.; Brown, J.